LncRNA LUCAT1 as a Plasma Biomarker for Assessing Disease Activity in Adult Patients with Crohn's Disease.
Xiao-Yi KuaiShun-Ying YuXiu-Fang CuiXiao-Jing ZhaoXia-Qiong MaoYang YuTong HuHong-Jie ZhangChun-Li ZhouPublished in: Gastroenterology research and practice (2021)
The plasma LncRNA LUCAT1 is positively associated with the disease activity in patients with CD, and it may act as a noninvasive biomarker to identify the degree of disease activity.